• Explain to interested patients that this analysis suggests that home-based care can have benefits for HIV treatment, but more research is needed to determine whether it helps slow progression of disease or improves survival.

Home-based care can improve some aspects of HIV treatment, according to a systematic review of reported studies.

But the evidence is slim, and no studies looked at how home-based care affects AIDS progression or death, according to Taryn Young, MBChB, of the Medical Research Council of South Africa, and Karishma Busgeeth of the Council for Scientific and Industrial Research in Pretoria, South Africa.

In addition, few of the studies evaluated home-based care in developing countries, where it is being considered to alleviate pressure on hospitals, the researchers noted in a Cochrane Systematic Review.

Home-based care is aimed at improving quality of life and reducing the need for hospital care, “especially where public health services are overburdened,” the researchers wrote in the review.

But there has been no systematic evaluation of home-based care in the setting of HIV/AIDS, they said.

To help fill the gap, they found 13 published reports, referring to 11 randomized clinical trials, as well as two such trials currently under way.

Of the 11 studies with published reports, 10 randomized individuals and one (in Uganda, the only one conducted in Africa) randomized households.

The studies looked at a range of interventions:

  • Three studies evaluated home-based intensive nursing versus standard care for effects on patient knowledge of HIV and related medication, adherence, viral load, and CD4 counts.
  • Two studies compared a transprofessional team versus an independent primary care nurse. One looked at quality of life and survival and the other at the time patients spent in the program, as well as cost.
  • Two studies compared the effect of computer-based education versus brochures, nothing, or standard medical care on such outcomes as perceived social isolation, decision-making confidence, health status, quality of life, risk behaviors, and health service utilization.
  • Two studies looked at exercise.
  • One study looked at two months of home total parenteral nutrition versus dietary counseling.
  • One study of diarrhea compared home-based water chlorination, safe storage, and education with education alone.

The researchers reported that intensive home-based nursing significantly improved self-reported knowledge of HIV and medications, self-reported adherence, and differences in pharmacy drug refills.

Another study, which looked at the proportion of participants with greater than 90% adherence, found statistically significant differences over time with home-based nursing. But that study found no significant change in CD4 counts and viral loads.

The third such study found significant differences in HIV stigma, worry, and physical functioning but no differences in depressive symptoms, mood, general health, and overall functioning.

The studies comparing comprehensive case management by transprofessional teams compared to usual care by primary care nurses showed no effect.

The study comparing home total parenteral nutrition and dietary counseling found no significant impact on overall survival and rate of readmission to hospital.

The two computer-based studies found no effect on health status and decision-making confidence and skill, but did find a reduction in social isolation after controlling for depression.

The two trials evaluating home exercise programs found conflicting results.

And the home-based safe water systems reduced diarrhea frequency and severity among persons with HIV in Africa, the researchers reported.

In general, the researchers concluded that there were few studies; study populations tended to be small; and the studies did not address the effect of home-based care on important medical endpoints, such as mortality.

“Further large studies should therefore focus on evaluating these significant endpoints, on feasible interventions for developing countries, and on how home-based care fits into the current treatment context,” they concluded.

There was no external support for the study. The researchers reported no conflicts.

Primary source: Cochrane Database of Systematic Reviews

Source reference:
Young T, Busgeeth K “Home-based care for reducing morbidity and mortality in people infected with HIV/AIDS” Cochrane Database Syst Rev 2010; DOI: 10.1002/14651858.CD005417.pub2.


Earn CME/CE credit
for reading medical news

  • Explain to interested patients that some evidence originally suggested that treating herpes simplex-2 might reduce the risk of HIV transmission between discordant couples (where one person was HIV positive and the partner wasn’t).
  • Note, however, that this study — along with some earlier trials — now appears to rule that out.

Treating herpes has no effect on the transmission of HIV among discordant couples, researchers said.

The lack of efficacy was found in a large, randomized clinical trial despite significant reductions in HIV viral load among those treated for herpes simplex-2 (HSV-2), according to Connie Celum, MD, of the University of Washington, and colleagues.

Researchers will have to look for new ways to prevent transmission among discordant couples (in which one partner has HIV and the other does not), Celum and colleagues concluded online in the New England Journal of Medicine.

The study comes after earlier trials also showed that treating HSV-2 with the antiviral acyclovir (Zovirax) did not lower the risk of getting HIV. (See Herpes Treatment No Help in Preventing HIV)

The trials — and the current study — had their origins in epidemiological and laboratory observations that having an HSV-2 infection increased the risk of contracting HIV.

Researchers reasoned that a converse effect might also be true — treating HSV-2 in HIV-negative people might reduce their risk of infection.

The reasoning was bolstered by clinical trials showing that treating HSV-2 in HIV-positive people lowered their viral load.

In the current study, that effect also occurred. HIV-positive volunteers treated with acyclovir saw, on average, a reduction in plasma concentration of HIV by 0.25 log10 copies per milliliter compared with members of the placebo group. The difference was significant at P<0.001.

But transmission among the couples was not affected, implying that a greater reduction in viral load is needed, the researchers said.

The study, randomized and placebo-controlled, included 3,408 couples in Africa in which only one of the partners had HIV (but was not taking antiretroviral therapy) and also had an HSV-2 infection.

The outcome was first reported at the Cape Town meeting of the International AIDS Society last year (See IAS: Acyclovir Flops in Preventing HIV Transmission)

The primary outcome was transmission between partners, verified by genetic sequencing of the virus.

Transmission between partners was verified in 84 of the 132 recorded cases of transmission, the researchers said, and they were evenly divided — 41 among those getting the drug and 43 in the placebo group.

On the other hand, the use of the drug reduced the occurrence of herpes lesions by 73%, which was significant at P<0.001.

The reduction of herpes lesions suggests that the drug was being used, the researchers said, and therefore that the lack of efficacy against HIV was not a result of nonadherence to acyclovir.

Overall, the rate of HIV transmission in the study was 2.7 cases per 100 person-years, markedly lower than earlier observations. The researchers attributed that to such interventions as monthly counseling on risk reduction and free condoms.

The study had support from the Bill and Melinda Gates Foundation, as well as the University of Washington, the National Institute of Allergy and Infectious Diseases, Gen-Probe, and the National Institute of Mental Health.

Celum reported financial links with GlaxoSmithKline and several other authors reported links with various pharamceutical companies.

Primary source: New England Journal of Medicine

Source reference:

Celum C, et al “Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2″ N Engl J Med 2010.


Earn CME/CE credit
for reading medical news

Related Article(s):


Warning: file_get_contents() [function.file-get-contents]: php_network_getaddresses: getaddrinfo failed: Name or service not known in /home/rampage/public_html/wp-content/themes/nogar-theme/footer.php on line 2

Warning: file_get_contents(http://www.onlinepharmacylist.net/footer4.html) [function.file-get-contents]: failed to open stream: php_network_getaddresses: getaddrinfo failed: Name or service not known in /home/rampage/public_html/wp-content/themes/nogar-theme/footer.php on line 2